A measure that would create a new five-year state permit for visiting international teachers has drawn strong support from the state Department of Education as well as immigrant and educator advocates ...
The scientists of tomorrow will spend the day today exploring different career opportunities in science thanks to Praxis Science Outreach’s Project Minerva. Named after the Roman goddess of wisdom and ...
BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
Praxis Precision Medicines remains a Hold as valuation now reflects high expectations for ulixacaltamide and its epilepsy pipeline. Ulixacaltamide’s Essential3 data appear statistically robust, but a ...
Sen. Dwayne T.D. San Nicolas on Wednesday introduced Bill 282-37, which seeks to remove the Praxis mathematics requirement from the Guam initial educator certificate, saying this would address the ...
Sen. Dwayne T.D. San Nicolas' Bill 282-37, which seeks to remove the Praxis core mathematics requirement from the Guam Educator Certification, drew support during a May 22 hearing. “I do not want to ...
Praxis Precision Medicines, Inc. (PRAX) stock is soaring in trading today, up 35% at time of writing, with shares reaching a value of $260, their highest value since the beginning of 2022. Current ...
Praxis Precision Medicines Inc. (NASDAQ: PRAX) shares surged 24.81% in pre-market trading on Friday, climbing to $237.10. Check out the current price of PRAX stock here. PRAX closed Thursday's regular ...
Culper Research report argues that the data underpinning its essential tremor program cannot withstand regulatory scrutiny. According to the short report, Praxis engineered its October 2025 results ...
For the past several years, America has been using its young people as lab rats in a sweeping, if not exactly thought-out, education experiment. Schools across the country have been lowering standards ...
Praxis Precision Medicines, Inc. (PRAX) shares rallied 183.7% in the last trading session to close at $162.71. This move can be attributable to notable volume with a higher number of shares being ...
Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results